These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33619326)

  • 1. Studies on metal-organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension.
    Mohamed NA; Abou-Saleh H; Kameno Y; Marei I; de Nucci G; Ahmetaj-Shala B; Shala F; Kirkby NS; Jennings L; Al-Ansari DE; Davies RP; Lickiss PD; Mitchell JA
    Sci Rep; 2021 Feb; 11(1):4336. PubMed ID: 33619326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
    Rashid J; Patel B; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
    J Control Release; 2017 Mar; 250():96-106. PubMed ID: 28185800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xinmai 'an extract enhances the efficacy of sildenafil in the treatment of pulmonary arterial hypertension via inhibiting MAPK signalling pathway.
    Zhu Y; Sun Y; Zhang S; Li C; Zhao Y; Zhao B; Li G
    Pharm Biol; 2021 Dec; 59(1):594-605. PubMed ID: 34010580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of sildenafil in fetal lambs on extracorporeal support.
    De Bie FR; Russo FM; Van Brantegem P; Coons BE; Moon JK; Yang Z; Pang C; Senra JC; Omann C; Annaert P; Allegaert K; Davey MG; Flake AW; Deprest J
    Biomed Pharmacother; 2021 Nov; 143():112161. PubMed ID: 34537676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor.
    Makled S; Nafee N; Boraie N
    Int J Pharm; 2017 Jan; 517(1-2):312-321. PubMed ID: 27979766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.
    Vizza CD; Jansa P; Teal S; Dombi T; Zhou D
    BMC Cardiovasc Disord; 2017 Sep; 17(1):239. PubMed ID: 28874133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Mendes-Ferreira P; Adão R; Brás-Silva C; Kinsella BT
    Eur J Pharmacol; 2020 Dec; 889():173658. PubMed ID: 33121950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of polymers on 3D microstructure and controlled release of sildenafil citrate from hydrophilic matrices.
    Krupa A; Tabor Z; Tarasiuk J; Strach B; Pociecha K; Wyska E; Wroński S; Łyszczarz E; Jachowicz R
    Eur J Pharm Sci; 2018 Jul; 119():234-243. PubMed ID: 29679708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Delivery of Sildenafil for Inhibiting Pulmonary Vascular Remodeling.
    Li B; He W; Ye L; Zhu Y; Tian Y; Chen L; Yang J; Miao M; Shi Y; Azevedo HS; Ma Z; Hao K
    Hypertension; 2019 Mar; 73(3):703-711. PubMed ID: 30636546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced nanoparticle accumulation by tumor-acidity-activatable release of sildenafil to induce vasodilation.
    Zhang P; Zhang Y; Ding X; Xiao C; Chen X
    Biomater Sci; 2020 Jun; 8(11):3052-3062. PubMed ID: 32347852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension.
    Beck-Broichsitter M; Hecker A; Kosanovic D; Schmehl T; Gessler T; Weissmann N; Ghofrani HA; Kissel T; Seeger W; Schermuly RT
    Nanomedicine; 2016 Jan; 12(1):63-8. PubMed ID: 26393885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous sildenafil in the management of pulmonary hypertension associated with congenital diaphragmatic hernia.
    Bialkowski A; Moenkemeyer F; Patel N
    Eur J Pediatr Surg; 2015 Apr; 25(2):171-6. PubMed ID: 24163194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
    Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
    Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization of Metal-Organic Framework Nanoparticles in Human Vascular Cells: Implications for Cardiovascular Disease Therapy.
    Al-Ansari DE; Mohamed NA; Marei I; Zekri A; Kameno Y; Davies RP; Lickiss PD; Rahman MM; Abou-Saleh H
    Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32471187
    [No Abstract]   [Full Text] [Related]  

  • 17. Degradation and Erosion of Metal-Organic Frameworks: Comparative Study of a NanoMIL-100 Drug Delivery System.
    Vuong MDL; Horbenko Y; Frégnaux M; Christodoulou I; Martineau-Corcos C; Levitz P; Rollet AL; Gref R; Haouas M
    ACS Appl Mater Interfaces; 2024 Jan; 16(2):2086-2100. PubMed ID: 38166380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials.
    Lombardi N; Crescioli G; Bettiol A; Ravaldi C; Vannacci A
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):437-438. PubMed ID: 30847998
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study.
    Hidayati F; Gharini PPR; Hartopo AB; Anggrahini DW; Dinarti LK
    Health Qual Life Outcomes; 2020 Aug; 18(1):278. PubMed ID: 32795300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension.
    Zayed R; Kamel AO; Shukr M; El-Shamy Ael-H
    Acta Pharm; 2012 Nov; 62(3):411-32. PubMed ID: 23470352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.